Redefining Facial Cancer Detection
AI-powered photonic diagnostics for faster, more accurate, and non-invasive facial disease detection.
Where AI Meets Clinical Insight
Cellunoma is a medical technology company pioneering facial medical recognition solutions that transform how clinicians detect and monitor facial conditions.
Our platform shifts care from subjective visual inspection to continuous, data-driven analysis—helping clinicians make faster, more confident decisions while improving patient outcomes.
Meet HAWA
HAWA is a non-invasive, AI-enabled photonic facial diagnostic mask designed for rapid detection, mapping, and triage of facial tumours, scars, and skin abnormalities.
By combining advanced imaging with intelligent analysis, HAWA reveals what the human eye cannot see—making early detection more accurate, scalable, and accessible.
Why Cellunoma
Cellunoma brings together advanced photonic imaging and explainable AI to deliver accurate, consistent, and real-time clinical insights. By reducing subjectivity and enabling early detection, our technology supports better decision-making and improved patient outcomes across every stage of care.
01
Early Detection
Identify subtle changes before they become critical
02
Objective Analysis
Move beyond subjective assessments with data-driven insights
03
Non-Invasive Technology
Safe, comfortable scanning with no disruption to patients
04
Faster Clinical Decisions
Real-time results with explainable AI outputs
How It Works Section
HAWA streamlines the diagnostic process into a simple, guided workflow that fits seamlessly into clinical routines. From capture to analysis, every step is designed to deliver accurate, consistent results while saving time and reducing variability between assessments.
Simple. Fast. Intelligent.
Earlier detection of facial cancers
Improved triage and clinical workflows
Improved triage and clinical workflows